Silo Pharma (SILO) entered into a non-binding Letter of Intent with Allucent to provide clinical research services for two planned Phase 1 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback